Boston-based Moderna has been the S&P 500’s most shorted stock since the end of September, according to S3 Partners. Short sellers had about $622mn of unrealised profits in the company in 2025, S3 …
Moderna is most shorted stock in S&P 500 as Americans skip jabs
view original post